Pay in 4 interest-free payments of $6.97 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
IGF-1 DESs short half-life makes it ideal for: Targeted injection into desired muscle groups Minimizing risk of systemic IGF-1 overexposure (which can lead to unwanted growth in non-target tissues) How It Differs From IGF-1 LR3 The DES(1-3) form of IGF-1 demonstrates higher potency for local anabolic effects due to enhanced receptor affinity and reduced binding to IGF binding proteins. Philippou et al., Cell Communication and Signaling Clinical & Performance Use Today While IGF-1 DES remains a research peptide and is not FDA-approved for human therapeutic use, it is widely used off-label by: Bodybuilders targeting lagging muscle groups (arms, calves, chest) Strength athletes recovering from tendon and ligament injuries Physique competitors preparing for contests Anti-aging practitioners promoting collagen synthesis and joint health It is also commonly stacked with: GH secretagogues (MK-677, CJC-1295, Ipamorelin) Recovery peptides (BPC-157 for Recovery, TB500) for comprehensive muscle growth + tissue repair protocols
Not all women experience the same results, some find that there are side effects associated with the medication such as nausea or headaches
80 YoshidaK.NoguchiK.MotohashiK.HisaboriT
Czares-Gallegos R, Silva-Vzquez R, Hernndez-Martnez CA, Gutirrez-Soto JG, Kawas-Garza JR, Hume ME, et al
Vesicular phospholipid gels as drug delivery systems for small molecular weight drugs, peptides and proteins: state of the art review
US$ 21.85
US$ 24.67
US$ 27.27
US$ 28.45
US$ 22.56
US$ 23.18
US$ 27.72